JP2005511662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511662A5 JP2005511662A5 JP2003548874A JP2003548874A JP2005511662A5 JP 2005511662 A5 JP2005511662 A5 JP 2005511662A5 JP 2003548874 A JP2003548874 A JP 2003548874A JP 2003548874 A JP2003548874 A JP 2003548874A JP 2005511662 A5 JP2005511662 A5 JP 2005511662A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- composition
- amino acid
- composition according
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000036639 antigens Human genes 0.000 claims 32
- 108091007433 antigens Proteins 0.000 claims 32
- 239000000427 antigen Substances 0.000 claims 30
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 102000004169 proteins and genes Human genes 0.000 claims 10
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 241000588653 Neisseria Species 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 4
- 239000003053 toxin Substances 0.000 claims 4
- 231100000765 toxin Toxicity 0.000 claims 4
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 241000588724 Escherichia coli Species 0.000 claims 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 2
- 101100038645 Streptomyces griseus rppA gene Proteins 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 241000588832 Bordetella pertussis Species 0.000 claims 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- 241001647372 Chlamydia pneumoniae Species 0.000 claims 1
- 241000606153 Chlamydia trachomatis Species 0.000 claims 1
- 102000009016 Cholera Toxin Human genes 0.000 claims 1
- 108010049048 Cholera Toxin Proteins 0.000 claims 1
- 101710146739 Enterotoxin Proteins 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 241000590002 Helicobacter pylori Species 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 241000709721 Hepatovirus A Species 0.000 claims 1
- 201000005505 Measles Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000588655 Moraxella catarrhalis Species 0.000 claims 1
- 208000005647 Mumps Diseases 0.000 claims 1
- 101100459189 Neisseria meningitidis serogroup B (strain MC58) mutS gene Proteins 0.000 claims 1
- 208000000474 Poliomyelitis Diseases 0.000 claims 1
- 241000605862 Porphyromonas gingivalis Species 0.000 claims 1
- 206010037742 Rabies Diseases 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000193985 Streptococcus agalactiae Species 0.000 claims 1
- 101000870438 Streptococcus gordonii UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase stabilizing protein GtfB Proteins 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 241000193996 Streptococcus pyogenes Species 0.000 claims 1
- 206010043376 Tetanus Diseases 0.000 claims 1
- 101000645119 Vibrio campbellii (strain ATCC BAA-1116 / BB120) Nucleotide-binding protein VIBHAR_03667 Proteins 0.000 claims 1
- 229940038705 chlamydia trachomatis Drugs 0.000 claims 1
- 206010013023 diphtheria Diseases 0.000 claims 1
- 239000000147 enterotoxin Substances 0.000 claims 1
- 231100000655 enterotoxin Toxicity 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 229940047650 haemophilus influenzae Drugs 0.000 claims 1
- 229940037467 helicobacter pylori Drugs 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 208000010805 mumps infectious disease Diseases 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 239000002510 pyrogen Substances 0.000 claims 1
- 201000005404 rubella Diseases 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129007.1A GB0129007D0 (en) | 2001-12-04 | 2001-12-04 | Adjuvanted antigenic meningococcal compositions |
| PCT/IB2002/005662 WO2003047619A2 (en) | 2001-12-04 | 2002-12-04 | Adjuvanted antigenic meningococcal compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009096521A Division JP2009155344A (ja) | 2001-12-04 | 2009-04-10 | アジュバント化された抗原性髄膜炎菌性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511662A JP2005511662A (ja) | 2005-04-28 |
| JP2005511662A5 true JP2005511662A5 (https=) | 2006-01-19 |
| JP4414226B2 JP4414226B2 (ja) | 2010-02-10 |
Family
ID=9926977
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003548874A Expired - Fee Related JP4414226B2 (ja) | 2001-12-04 | 2002-12-04 | アジュバント化された抗原性髄膜炎菌性組成物 |
| JP2009096521A Withdrawn JP2009155344A (ja) | 2001-12-04 | 2009-04-10 | アジュバント化された抗原性髄膜炎菌性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009096521A Withdrawn JP2009155344A (ja) | 2001-12-04 | 2009-04-10 | アジュバント化された抗原性髄膜炎菌性組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20060008476A1 (https=) |
| EP (1) | EP1448230B1 (https=) |
| JP (2) | JP4414226B2 (https=) |
| AP (1) | AP2004003074A0 (https=) |
| AT (1) | ATE485055T1 (https=) |
| AU (1) | AU2002353417A1 (https=) |
| CA (1) | CA2468935C (https=) |
| CY (1) | CY1111114T1 (https=) |
| DE (1) | DE60238075D1 (https=) |
| GB (1) | GB0129007D0 (https=) |
| WO (1) | WO2003047619A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| NZ521531A (en) * | 2000-02-28 | 2005-12-23 | Chiron S | Heterologous expression of neisserial proteins |
| AU2002346249B2 (en) * | 2001-06-07 | 2007-03-15 | The Regents Of The University Of Colorado | Mutant Forms of Cholera Holotoxin as an Adjuvant |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| NZ536859A (en) * | 2002-05-14 | 2007-11-30 | Chiron Srl | Mucosal combination vaccines for bacterial meningitis |
| GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| NZ546430A (en) | 2003-10-02 | 2009-04-30 | Novartis Vaccines & Diagnostic | Liquid vaccines for multiple meningococcal serogroups |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| EP2411048B1 (en) | 2009-03-24 | 2020-05-06 | GlaxoSmithKline Biologicals SA | Adjuvanting meningococcal factor h binding protein |
| CN107913396B (zh) | 2010-08-23 | 2022-03-08 | 惠氏有限责任公司 | 脑膜炎萘瑟氏菌rLP2086抗原的稳定制剂 |
| AU2011300409B2 (en) | 2010-09-10 | 2015-03-26 | Wyeth Llc | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens |
| WO2012059593A1 (en) * | 2010-11-05 | 2012-05-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Vaccines for preventing meningococcal infections |
| GB201102090D0 (en) * | 2011-02-08 | 2011-03-23 | Univ Sheffield | Antigenic polypeptide |
| MY198910A (en) | 2012-03-09 | 2023-10-02 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| WO2014016152A1 (en) | 2012-07-27 | 2014-01-30 | Institut National De La Sante Et De La Recherche Medicale | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| WO2014136064A2 (en) | 2013-03-08 | 2014-09-12 | Pfizer Inc. | Immunogenic fusion polypeptides |
| RU2662968C2 (ru) | 2013-09-08 | 2018-07-31 | Пфайзер Инк. | Иммуногенная композиция против neisseria meningitidis (варианты) |
| WO2016132294A1 (en) | 2015-02-19 | 2016-08-25 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| AU2018215585B2 (en) | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| EP3897706A4 (en) | 2018-12-21 | 2022-11-23 | Griffith University | COMPOSITIONS, METHODS AND USES FOR INDURING AN IMMUNE RESPONSE |
| WO2021059181A1 (en) | 2019-09-27 | 2021-04-01 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| WO2021067628A2 (en) * | 2019-10-01 | 2021-04-08 | Beth Israel Deaconess Medical Center, Inc. | Conformation-specific antibodies that bind nuclear factor kappa-light-chain-enhancer of activated b cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| CA2671261A1 (en) * | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| EP1047784B2 (en) * | 1998-01-14 | 2015-03-18 | Novartis Vaccines and Diagnostics S.r.l. | Neissera meningitidis antigens |
| PT1117435E (pt) * | 1998-09-30 | 2008-02-21 | Us Gov Univ Health Sciences | Holotoxina da cólera mutante como adjuvante |
| US7384640B1 (en) * | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
-
2001
- 2001-12-04 GB GBGB0129007.1A patent/GB0129007D0/en not_active Ceased
-
2002
- 2002-12-04 DE DE60238075T patent/DE60238075D1/de not_active Expired - Lifetime
- 2002-12-04 CA CA2468935A patent/CA2468935C/en not_active Expired - Fee Related
- 2002-12-04 AT AT02788442T patent/ATE485055T1/de not_active IP Right Cessation
- 2002-12-04 AU AU2002353417A patent/AU2002353417A1/en not_active Abandoned
- 2002-12-04 AP APAP/P/2004/003074A patent/AP2004003074A0/en unknown
- 2002-12-04 JP JP2003548874A patent/JP4414226B2/ja not_active Expired - Fee Related
- 2002-12-04 WO PCT/IB2002/005662 patent/WO2003047619A2/en not_active Ceased
- 2002-12-04 US US10/497,709 patent/US20060008476A1/en not_active Abandoned
- 2002-12-04 EP EP02788442A patent/EP1448230B1/en not_active Expired - Lifetime
-
2009
- 2009-04-10 JP JP2009096521A patent/JP2009155344A/ja not_active Withdrawn
-
2010
- 2010-05-25 US US12/787,366 patent/US20100233205A1/en not_active Abandoned
-
2011
- 2011-01-18 CY CY20111100056T patent/CY1111114T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511662A5 (https=) | ||
| JP4662537B2 (ja) | 細菌性髄膜炎に関する粘膜組合せワクチン | |
| JP4696260B2 (ja) | キトサンアジュンバントおよび髄膜炎菌抗原を用いる粘膜ワクチン | |
| JP2003520248A5 (https=) | ||
| Ruggiero et al. | The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? | |
| WO1998058668A2 (en) | Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae | |
| McCluskie et al. | Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants | |
| JP4414226B2 (ja) | アジュバント化された抗原性髄膜炎菌性組成物 | |
| JP2005508156A (ja) | ナイセリアタンパク質のハイブリッドおよびタンデム発現 | |
| CN102905726A (zh) | 包含抗原和Toll样受体激动剂的口服疫苗 | |
| JP2002516292A (ja) | 組合わせの髄膜炎菌ｂ／ｃワクチン | |
| JP4522699B2 (ja) | アジュバント化されたＭｅｎｉｎｇｏｃｏｃｃｕｓ組成物 | |
| CN1195297A (zh) | 艰难梭菌毒素作为粘膜佐剂 | |
| Lee et al. | Vaccination and mucosal responses to Helicobacter pylori infection. | |
| JPH0840927A (ja) | 肺炎球菌抗原の経粘膜投与方法 | |
| AU733845B2 (en) | Immunogenic complex, use, method of preparation thereof and vaccine containing same | |
| TW202038991A (zh) | 百日咳追加疫苗 | |
| US20110236414A1 (en) | Bacterial Polysaccharide-Polypeptide Conjugate Compositions | |
| JP4554268B2 (ja) | 分泌型ＩｇＡ抗体誘導剤 | |
| JP2634545B2 (ja) | Ｒｔｘトキシンファミリーに属する細菌毒素ワクチンの製造法 | |
| JP2005082581A (ja) | 分泌型ＩｇＡ抗体誘導剤 | |
| CN107080841A (zh) | 基于重组载体蛋白的霍乱‑轮状病毒联合疫苗及其制备方法 | |
| CN107080840B (zh) | 轮状病毒-霍乱联合疫苗及其制备方法 | |
| RU2360699C2 (ru) | Композиции менингококковых вакцин с адъювантами | |
| KR20210068429A (ko) | 점막 애주번트 |